Role of Nano Particle Drug Delivery System in Antifungal Therapy

Anil Kumar Thummamaluru

doi:10.37022/jpmhs.v7i3.114

Authors

Thummamaluru Anil Kumar Priyadarshini Institute of Pharmaceutical Education and Research, 5th Mile, Pulladigunta, Guntur-522017.Andhra Pradesh, India.

DOI:

https://doi.org/10.37022/jpmhs.v7i3.114

Keywords:

Nanoparticles, Nanomaterial, Contaminations, Antifungal

Abstract

Effective illnesses are currently treated with oral and common effective strategies. Oral and effective courses encounter numerous challenges, including pharmaceutical drug interactions, higher metabolic rate, unfavorable retention, and toxicity. Controlled drug release has not been demonstrated using conventionally useful measuring forms such as gels, salves, and creams. According to written accounts, several lakhs of people are affected and over 1.5 lakh people are thought to have died as a result of infectious contaminations. The high prevalence of parasite infections, which has been disrupted by an expansion in inclination factors, has become a concerning general medical issue. It is essential to thoroughly investigate the relationships between the specifics, the organization method, pharmacological properties, pharmacokinetics, pharmacodynamics, strength, sufficiency, safety, and clinical signs in order to improve a successful novel antifungal medication delivery framework. This audit article looks at several types of nanoparticle processes that are used to deliver antifungal drugs, such as dendrimers, polymeric nanoparticles, inorganic nanoparticles, and nanoparticles based on phospholipids (nanovesicles).

Downloads

Download data is not yet available.

References

Nagasa GD, Belete A. Review on nanomaterials and nano-scaled systems for topical and systemic delivery of antifungal drugs. Journal of Multidisciplinary Healthcare. 2022 Jan 1:1819-40.

Rai M, Ingle AP, Pandit R, Paralikar P, Gupta I, Anasane N, Dolenc-Voljč M. Nanotechnology for the treatment of fungal infections on human skin. InThe microbiology of skin, soft tissue, bone and joint infections 2017 Jan 1 (pp. 169-184). Academic Press.

Nami S, Aghebati-Maleki A, Morovati H, Aghebati-Maleki L. Current antifungal drugs and immunotherapeutic approaches as promising strategies to treatment of fungal diseases. Biomedicine & Pharmacotherapy. 2019 Feb 1;110:857-68.

Rani TT, Brahmaiah B, Revathi B, Nama S, Baburao C. TARGETING OF ANTI CANCER DRUGS THROUGH NANOPARTICLES.

Faisal W, Soliman GM, Hamdan AM. Enhanced skin deposition and delivery of voriconazole using ethosomal preparations. Journal of liposome research. 2018 Jan 2;28(1):14-21.

Akhtar N, Varma A, Pathak K. Ethosomes as vesicles for effective transdermal delivery: from bench to clinical implementation. Current clinical pharmacology. 2016 Aug 1;11(3):168-90.

Sahoo SS, Rao C, Mehta A. Formulation development and optimization of nanosuspension of simvastatin for improved solubility by nanomilling. J. Pharm SciTech. 2015;5(2):78-86.

Aditya K G, Jennifer E R, Melody C, Elizabeth A C. Dermatophytosis: the management of fungal infections. SKINmed: Dermatology for the Clinician. 2005 Sep;4(5):305-10.

Firooz A, Nafisi S, Maibach HI. Novel drug delivery strategies for improving econazole antifungal action. International journal of pharmaceutics. 2015 Nov 10;495(1):599-607.

Sousa F, Ferreira D, Reis S, Costa P. Current insights on antifungal therapy: Novel nanotechnology approaches for drug delivery systems and new drugs from natural sources. Pharmaceuticals. 2020 Sep 15;13(9):248.

Lewis RE. Current concepts in antifungal pharmacology. InMayo Clinic Proceedings 2011 Aug 1 (Vol. 86, No. 8, pp. 805-817). Elsevier.

Khatry SK, Lewis AE, Schein OD, Thapa MD, Pradhan EK, Katz J. The epidemiology of ocular trauma in rural Nepal. British journal of ophthalmology. 2004 Apr 1;88(4):456-60.

Asghari F, Jahanshiri Z, Imani M, Shams-Ghahfarokhi M, Razzaghi-Abyaneh M. Antifungal nanomaterials: synthesis, properties, and applications. InNanobiomaterials in antimicrobial therapy 2016 Jan 1 (pp. 343-383). William Andrew Publishing.

Amulya A, Sirisha V, Rao CB, Chennam JV. CURRENT TRENDS ON ROLE OF NANO PARTICLES ON PULMONARY DISEASES. International Journal of Research in Pharmacy and Chemistry. 2012;2(3):685-703.

Slavin YN, Asnis J, Hńfeli UO, Bach H. Metal nanoparticles: understanding the mechanisms behind antibacterial activity. Journal of nanobiotechnology. 2017 Dec;15:1-20.

Bozzuto G, Molinari A. Liposomes as nanomedical devices. International journal of nanomedicine. 2015 Feb 2:975-99.

Nicolini C. Ethanol based vesicular carriers in transdermal drug delivery: nanoethosomes and transethosomes in focus. NanoWorld journal. 2016 Oct 26;1(2).

Abbasi E, Milani M, Fekri Aval S, Kouhi M, Akbarzadeh A, Tayefi Nasrabadi H, Nikasa P, Joo SW, Hanifehpour Y, Nejati-Koshki K, Samiei M. Silver nanoparticles: synthesis methods, bio-applications and properties. Critical reviews in microbiology. 2016 Mar 3;42(2):173-80.

Namballa M, Adimulapu A, Jesudasan RE. QbD Assisted Optimization of Microwave-assisted Synthesis of Polyacrylamide Grafted Tragacanth: Characterization and Instrumental Analysis. Current Microwave Chemistry. 2024 Apr 1;11(1):16-29.

Niemirowicz K, Durnaś B, Tokajuk G, Piktel E, Michalak G, Gu X, Kułakowska A, Savage PB, Bucki R. Formulation and candidacidal activity of magnetic nanoparticles coated with cathelicidin LL-37 and ceragenin CSA-13. Scientific Reports. 2017 Jul 4;7(1):4610.

Palmer BC, DeLouise LA. Nanoparticle-enabled transdermal drug delivery systems for enhanced dose control and tissue targeting. Molecules. 2016 Dec 15;21(12):1719.

Crucho CI, Barros MT. Polymeric nanoparticles: A study on the preparation variables and characterization methods. Materials Science and Engineering: C. 2017 Nov 1;80:771-84.

Wang AZ, Yuet K, Zhang L, Gu FX, Huynh-Le M, Radovic-Moreno AF, Kantoff PW, Bander NH, Langer R, Farokhzad OC. ChemoRad nanoparticles: a novel multifunctional nanoparticle platform for targeted delivery of concurrent chemoradiation. Nanomedicine. 2010 Apr;5(3):361-8.

Tripathy S, Das MK. Dendrimers and their applications as novel drug delivery carriers. Journal of Applied Pharmaceutical Science. 2013 Sep 30;3(9):142-9.